In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract manufacturer Senn Chemicals. The deal, once closed, will immediately ...

Granules India Ltd share price was up by 0.15% from the previous closing price of ₹495.50. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals Industries ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Mycetoma is a chronic, subcutaneous infection that causes local tissue destruction, leading to deformity, disability, and social stigma. Safe and effective treatments for mycetoma are urgently needed; ...

Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The move enhances Granules' CDMO capabilities, leveraging Senn's ...

Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs ...

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 12,033.75 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...